FDA Chief Advocates for Innovative, Real-Time Clinical Trials to Revolutionize Drug Development - Top-Institutions - MDSpire

FDA Chief Advocates for Innovative, Real-Time Clinical Trials to Revolutionize Drug Development

  • By

  • Marty Makary

  • April 28, 2026

  • 0 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Oncology
    • Clinical Trial Innovation
    • Biomedical Informatics

  • #2

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Cancer Clinical Trials
    • Translational Research
    • Data Science

  • #3

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Clinical Trial Design
    • Biomedical Informatics
    • Oncology

  • #4

    Amgen Inc.
    Amgen Inc.

    Thousand Oaks, CA

    Key Differentiators

    • Pharmaceutical Clinical Trials
    • Biotechnology
    • Data Science

Original Source(s)

FDA Chief Advocates for Innovative, Real-Time Clinical Trials to Revolutionize Drug Development

  • by Marty Makary

  • April 28, 2026

Related Content

Detecting comorbidity patterns in rare disease patients with machine learning

Reevaluating the Alcohol–Cancer Link: Long-Term Cancer Mortality Outcomes in the REGARDS Study

Immunological and Pathological Roles of Siglecs: A Molecular Review